Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?H J Andreyev, A R Norman, J Oates, et al.Gut|June 1, 1994
Association between Meckel's diverticulum and Crohn's disease: a retrospective reviewH J Andreyev, R A Owen, I Thompson, et al.Gut|January 13, 2001
Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinomaH J Andreyev, P J Ross, D Cunningham, et al.Journal of Clinical Gastroenterology|July 1, 1996
Joint symptoms after restorative proctocolectomy in ulcerative colitis and familial polyposis coliH J Andreyev, M A Kamm, A Forbes, et al.The American Journal of Gastroenterology|September 1, 1994
Acid secretion from a Meckel's diverticulum: the unsuspected mimic of Crohn's disease?H J Andreyev, R A Owen, P A Thomas, et al.Journal of the National Cancer Institute|May 20, 1998
Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" studyH J Andreyev, A R Norman, D Cunningham, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|May 10, 2011
Late-onset bowel dysfunction after pelvic radiotherapy: a national survey of current practice and opinions of clinical oncologistsC C Henson, H J Andreyev, R P Symonds, et al.Molecular Cancer Therapeutics|December 7, 2002
Inhibition of Kirsten-ras expression in human colorectal cancer using rationally selected Kirsten-ras antisense oligonucleotidesP J Ross, M George, D Cunningham, et al.European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Squamous oesophageal cancer can be downstaged using protracted venous infusion of 5-fluorouracil with epirubicin and cisplatin (ECF)H J Andreyev, A R Norman, D Cunningham, et al.British Journal of Cancer|January 1, 1997
Bcl-2 expression and response to chemotherapy in colorectal adenocarcinomasH J Schneider, S A Sampson, D Cunningham, et al.Pageof 2